Consensus for FY24 EPS is $3.19. Raises FY24 revenue view to $1.672B-$1.687B from $1.603B-$1.618B, consensus $1.62B.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IART:
- Is IART a Buy, Before Earnings?
- Integra LifeSciences to Spotlight CereLink® Intracranial Pressure (ICP) Monitoring System at the American Association of Neurological Surgeons (AANS) Annual Scientific Meeting
- Medicare Administrators looking to ‘drastically shake up’ wound care, says BTIG
- Integra LifeSciences to Reschedule the First Quarter 2024 Financial Results Conference Call to May 6, 2024
- UPS upgraded, PepsiCo downgraded: Wall Street’s top analyst calls